2024-11-18 10:41:45
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study
Health/ 2023-07-22
Minghui Pharmaceutical Inc. Announces Fi...

SHANGHAI and HANGZHOU,China and WILMINGTON,Del.,May 23,2023-- Minghui Pharmaceutical,Inc.,a clinical-stage biopharmaceutical company focusin...

Strong first quarter 2023: Sales of Exyte increases by a third year-on year to 2.0 billion euros
Health/ 2023-07-22
Strong first quarter 2023: Sales of Exyt...

Significant sales increase by 33,6% to €2.0 billion year-on-year Substantial growth of adjusted EBIT and adjusted EBITDA of around 19% to €...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release